{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:01:59Z","timestamp":1785477719258,"version":"3.56.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82394433\/82361148130"],"award-info":[{"award-number":["82394433\/82361148130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI radiopharm. chem."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colony-stimulating factor 1 receptor (CSF1R) is a promising imaging biomarker for neuroinflammation and tumor-associated macrophages. However, existing positron emission tomography (PET) tracers for CSF1R imaging often suffer from limited specificity or sensitivity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We have performed\n                      <jats:sup>11<\/jats:sup>\n                      C-labeled radiosynthesis of compound FJRD (3-((2-amino-5-(1-methyl-1\n                      <jats:italic>H<\/jats:italic>\n                      -pyrazol-4-yl)pyridin-3-yl)ethynyl)-\n                      <jats:italic>N<\/jats:italic>\n                      -(4-methoxyphenyl)-4-methylbenzamide), which exhibits excellent affinity for CSF1R, and evaluated its in vivo and in vitro binding properties. PET images of [\n                      <jats:sup>11<\/jats:sup>\n                      C]FJRD show low brain uptake and specific binding in the living organs, except the kidneys in both normal mice and rats. In vitro autoradiographs demonstrate high levels of specific binding in all investigated organs, including the brain, spleen, liver, kidneys and lungs, when self-blocking was used. The addition of CPPC partially blocked in vitro [\n                      <jats:sup>11<\/jats:sup>\n                      C]FJRD binding in these organs, with blocking effects ranging from 9 to 67%. In contrast, the other two CSF1R inhibitors, GW2580 and BLZ945, showed minimal blocking effects, suggesting unignorable off-target binding in these organs. Furthermore, specific binding of [\n                      <jats:sup>11<\/jats:sup>\n                      C]CPPC and [\n                      <jats:sup>11<\/jats:sup>\n                      C]GW2580 was faint in the mouse organs, with [\n                      <jats:sup>11<\/jats:sup>\n                      C]CPPC demonstrating detectable binding only in the spleen.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      These results suggest that [\n                      <jats:sup>11<\/jats:sup>\n                      C]FJRD is a potential CSF1R-PET tracer for more sensitive detection of CSF1R, compared to [\n                      <jats:sup>11<\/jats:sup>\n                      C]CPPC and [\n                      <jats:sup>11<\/jats:sup>\n                      C]GW2580. However, the high level off-target binding necessitates further improvements in specificity for CSF1R imaging.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41181-025-00345-8","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T14:26:59Z","timestamp":1747146419000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of in vivo and in vitro binding property of a novel candidate PET tracer for CSF1R imaging and comparison with two currently-used CSF1R-PET tracers"],"prefix":"10.1186","volume":"10","author":[{"given":"Xiyan","family":"Rui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhou","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nailian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoteru","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Fujinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0004-8621","authenticated-orcid":false,"given":"Rong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"345_CR16","doi-asserted-by":"publisher","first-page":"117628","DOI":"10.1016\/j.bmc.2024.117628","volume":"100","author":"A Adhikari","year":"2024","unstructured":"Adhikari A, Chauhan K, Adhikari M, Tiwari AK. Colony stimulating Factor-1 receptor: an emerging target for neuroinflammation PET imaging and AD therapy. Bioorg Med Chem. 2024;100:117628.","journal-title":"Bioorg Med Chem"},{"issue":"11","key":"345_CR15","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1021\/acsptsci.3c00213","volume":"6","author":"S Altomonte","year":"2023","unstructured":"Altomonte S, Pike VW. Candidate tracers for imaging Colony-Stimulating factor 1 receptor in neuroinflammation with positron emission tomography: issues and progress. ACS Pharmacol Transl Sci. 2023;6(11):1632\u201350.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"4","key":"345_CR10","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1021\/acsptsci.3c00003","volume":"6","author":"S Altomonte","year":"2023","unstructured":"Altomonte S, Yan X, Morse CL, Liow JS, Jenkins MD, Montero Santamaria JA, Zoghbi SS, Innis RB, Pike VW. Discovery of a High-Affinity fluoromethyl analog of [(11)C]5-Cyano-N-(4-(4-methylpiperazin-1-yl)-2-(piperidin-1-yl)phenyl)furan-2-carboxamide ([(11)C]CPPC) and their comparison in mouse and monkey as Colony-Stimulating factor 1 receptor positron emission tomography radioligands. ACS Pharmacol Transl Sci. 2023;6(4):614\u201332.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"345_CR18","doi-asserted-by":"publisher","first-page":"117233","DOI":"10.1016\/j.bmc.2023.117233","volume":"83","author":"X An","year":"2023","unstructured":"An X, Wang J, Tong L, Zhang X, Fu H, Zhang J, Xie H, Huang Y, Jia H. (18)F-Labeled o\u2013aminopyridyl alkynyl radioligands targeting colony-stimulating factor 1 receptor for neuroinflammation imaging. Bioorg Med Chem. 2023;83:117233.","journal-title":"Bioorg Med Chem"},{"issue":"3","key":"345_CR7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/cei.13649","volume":"206","author":"W Beaino","year":"2021","unstructured":"Beaino W, Janssen B, Vugts DJ, de Vries HE, Windhorst AD. Towards PET imaging of the dynamic phenotypes of microglia. Clin Exp Immunol. 2021;206(3):282\u2013300.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"345_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40425-017-0257-y","volume":"5","author":"MA Cannarile","year":"2017","unstructured":"Cannarile MA, Weisser M, Jacob W, Jegg AM, Ries CH, Ruttinger D. Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy. J Immunother Cancer. 2017;5(1):53.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"345_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13550-022-00929-4","volume":"12","author":"JM Coughlin","year":"2022","unstructured":"Coughlin JM, Du Y, Lesniak WG, Harrington CK, Brosnan MK, O\u2019Toole R, Zandi A, Sweeney SE, Abdallah R, Wu Y, Holt DP, Hall AW, Dannals RF, Solnes L, Horti AG, Pomper MG. First-in-human use of (11)C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor. EJNMMI Res. 2022;12(1):64.","journal-title":"EJNMMI Res"},{"key":"345_CR3","doi-asserted-by":"crossref","unstructured":"Da Ros M, De Gregorio V, Iorio AL, Giunti L, Guidi M, de Martino M, Genitori L, Sardi I. Glioblastoma chemoresistance: the double play by microenvironment and Blood-Brain barrier. Int J Mol Sci 2018;19(10).","DOI":"10.3390\/ijms19102879"},{"issue":"8","key":"345_CR6","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1158\/1535-7163.MCT-20-0591","volume":"20","author":"T Fujiwara","year":"2021","unstructured":"Fujiwara T, Yakoub MA, Chandler A, Christ AB, Yang G, Ouerfelli O, Rajasekhar VK, Yoshida A, Kondo H, Hata T, Tazawa H, Dogan Y, Moore MAS, Fujiwara T, Ozaki T, Purdue E, Healey JH. CSF1\/CSF1R signaling inhibitor pexidartinib (PLX3397) reprograms Tumor-Associated macrophages and stimulates T-cell infiltration in the sarcoma microenvironment. Mol Cancer Ther. 2021;20(8):1388\u201399.","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"345_CR2","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.it.2020.07.001","volume":"41","author":"KN Green","year":"2020","unstructured":"Green KN, Crapser JD, Hohsfield LA. To kill a microglia: A case for CSF1R inhibitors. Trends Immunol. 2020;41(9):771\u201384.","journal-title":"Trends Immunol"},{"issue":"2","key":"345_CR22","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3233\/JAD-170745","volume":"61","author":"R Harris","year":"2018","unstructured":"Harris R, Miners JS, Allen S, Love S. VEGFR1 and VEGFR2 in Alzheimer\u2019s disease. J Alzheimers Dis. 2018;61(2):741\u201352.","journal-title":"J Alzheimers Dis"},{"issue":"26","key":"345_CR19","doi-asserted-by":"publisher","first-page":"7559","DOI":"10.1021\/jm060642i","volume":"49","author":"SA Hitchcock","year":"2006","unstructured":"Hitchcock SA. Structure\u2013brain exposure relationships. J Med Chem. 2006;49(26):7559\u201383.","journal-title":"J Med Chem"},{"issue":"5","key":"345_CR13","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1073\/pnas.1812155116","volume":"116","author":"AG Horti","year":"2019","unstructured":"Horti AG, Naik R, Foss CA, Minn I, Misheneva V, Du Y, Wang Y, Mathews WB, Wu Y, Hall A, LaCourse C, Ahn HH, Nam H, Lesniak WG, Valentine H, Pletnikova O, Troncoso JC, Smith MD, Calabresi PA, Savonenko AV, Dannals RF, Pletnikov MV, Pomper M. G., PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R). Proc Natl Acad Sci U S A. 2019;116(5):1686\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"47","key":"345_CR26","doi-asserted-by":"publisher","first-page":"12255","DOI":"10.1523\/JNEUROSCI.2312-08.2008","volume":"28","author":"B Ji","year":"2008","unstructured":"Ji B, Maeda J, Sawada M, Ono M, Okauchi T, Inaji M, Zhang MR, Suzuki K, Ando K, Staufenbiel M, Trojanowski JQ, Lee VM, Higuchi M, Suhara T. Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer\u2019s and other CNS pathologies. J Neurosci. 2008;28(47):12255\u201367.","journal-title":"J Neurosci"},{"issue":"2","key":"345_CR24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s10637-022-01325-4","volume":"41","author":"Z Kang","year":"2023","unstructured":"Kang Z, Li S, Lin Y, Li Y, Mao Y, Zhang J, Lei T, Wang H, Su Y, Yang Y, Qiu J, Li W. A phase I dose-escalation study of SYHA1813, a VEGFR and CSF1R inhibitor, in patients with recurrent High-Grade gliomas or advanced solid tumors. Invest New Drugs. 2023;41(2):296\u2013305.","journal-title":"Invest New Drugs"},{"issue":"6","key":"345_CR12","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1021\/acschemneuro.0c00802","volume":"12","author":"AC Knight","year":"2021","unstructured":"Knight AC, Varlow C, Zi T, Liang SH, Josephson L, Schmidt K, Patel S, Vasdev N. In vitro evaluation of [(3)H]CPPC as a tool radioligand for CSF-1R. ACS Chem Neurosci. 2021;12(6):998\u20131006.","journal-title":"ACS Chem Neurosci"},{"key":"345_CR11","doi-asserted-by":"crossref","unstructured":"Mills KA, Du Y, Coughlin JM, Foss CA, Horti AG, Jenkins K, Skorobogatova Y, Spiro E, Motley CS, Dannals RF, Song JJ, Choi YR, Redding-Ochoa J, Troncoso J, Dawson VL, Kam TI, Pomper MG, Dawson TM. Exploring [(11)C]CPPC as a CSF1R-targeted PET Imaging Marker for Early Parkinson\u2019s Disease Severity. medRxiv 2024.","DOI":"10.1101\/2023.05.28.23290647"},{"issue":"8","key":"345_CR4","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.tips.2022.04.002","volume":"43","author":"L Pang","year":"2022","unstructured":"Pang L, Khan F, Dunterman M, Chen P. Pharmacological targeting of the tumor-immune symbiosis in glioblastoma. Trends Pharmacol Sci. 2022;43(8):686\u2013700.","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"345_CR25","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1111\/j.1523-1755.2004.00621.x","volume":"65","author":"BF Schrijvers","year":"2004","unstructured":"Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int. 2004;65(6):2003\u201317.","journal-title":"Kidney Int"},{"issue":"Pt 4","key":"345_CR1","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/brain\/aww016","volume":"139","author":"EE Spangenberg","year":"2016","unstructured":"Spangenberg EE, Lee RJ, Najafi AR, Rice RA, Elmore MR, Blurton-Jones M, West BL, Green KN. Eliminating microglia in Alzheimer\u2019s mice prevents neuronal loss without modulating amyloid-beta pathology. Brain. 2016;139(Pt 4):1265\u201381.","journal-title":"Brain"},{"key":"345_CR8","doi-asserted-by":"crossref","unstructured":"Tronel C, Largeau B, Santiago Ribeiro MJ, Guilloteau D, Dupont AC, Arlicot N. Molecular targets for PET imaging of activated microglia: the current situation and future expectations. Int J Mol Sci 2017;18(4).","DOI":"10.3390\/ijms18040802"},{"issue":"23","key":"345_CR20","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1021\/acschemneuro.1c00641","volume":"12","author":"B van der Wildt","year":"2021","unstructured":"van der Wildt B, Janssen B, Pekosak A, Steen EJL, Schuit RC, Kooijman EJM, Beaino W, Vugts DJ, Windhorst AD. Novel Thienopyrimidine-Based PET tracers for P2Y(12) receptor imaging in the brain. ACS Chem Neurosci. 2021a;12(23):4465\u201374.","journal-title":"ACS Chem Neurosci"},{"key":"345_CR21","doi-asserted-by":"publisher","first-page":"116245","DOI":"10.1016\/j.bmc.2021.116245","volume":"42","author":"B van der Wildt","year":"2021","unstructured":"van der Wildt B, Nezam M, Kooijman EJM, Reyes ST, Shen B, Windhorst AD, Chin FT. Evaluation of carbon-11 labeled 5-(1-methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamide as PET tracer for imaging of CSF-1R expression in the brain. Bioorg Med Chem. 2021b;42:116245.","journal-title":"Bioorg Med Chem"},{"key":"345_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.nucmedbio.2021.06.005","volume":"100\u2013101","author":"B van der Wildt","year":"2021","unstructured":"van der Wildt B, Miao Z, Reyes ST, Park JH, Klockow JL, Zhao N, Romero A, Guo SG, Shen B, Windhorst AD, Chin FT. BLZ945 derivatives for PET imaging of colony stimulating factor-1 receptors in the brain. Nucl Med Biol. 2021c;100\u2013101:44\u201351.","journal-title":"Nucl Med Biol"},{"key":"345_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.nucmedbio.2022.10.003","volume":"114\u2013115","author":"B van der Wildt","year":"2022","unstructured":"van der Wildt B, Klockow JL, Miao Z, Reyes ST, Park JH, Shen B, Chin FT. Discovery of a CSF-1R inhibitor and PET tracer for imaging of microglia and macrophages in the brain. Nucl Med Biol. 2022;114\u2013115:99\u2013107.","journal-title":"Nucl Med Biol"},{"issue":"3","key":"345_CR17","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1021\/acs.jmedchem.9b01912","volume":"63","author":"Z Xie","year":"2020","unstructured":"Xie Z, Wu B, Liu Y, Ren W, Tong L, Xiang C, Wei A, Gao Y, Zeng L, Xie H, Tang W, Hu Y. Novel class of Colony-Stimulating factor 1 receptor kinase inhibitors based on an o-Aminopyridyl alkynyl scaffold as potential treatment for inflammatory disorders. J Med Chem. 2020;63(3):1397\u2013414.","journal-title":"J Med Chem"},{"issue":"9","key":"345_CR9","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1177\/0271678X211004146","volume":"41","author":"X Zhou","year":"2021","unstructured":"Zhou X, Ji B, Seki C, Nagai Y, Minamimoto T, Fujinaga M, Zhang MR, Saito T, Saido TC, Suhara T, Kimura Y, Higuchi M. PET imaging of colony-stimulating factor 1 receptor: A head-to-head comparison of a novel Radioligand, (11)C-GW2580, and (11)C-CPPC, in mouse models of acute and chronic neuroinflammation and a rhesus monkey. J Cereb Blood Flow Metab. 2021;41(9):2410\u201322.","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["EJNMMI Radiopharmacy and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-025-00345-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41181-025-00345-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-025-00345-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T14:27:10Z","timestamp":1747146430000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmipharmchem.springeropen.com\/articles\/10.1186\/s41181-025-00345-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["345"],"URL":"https:\/\/doi.org\/10.1186\/s41181-025-00345-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6194254\/v1","asserted-by":"object"}]},"ISSN":["2365-421X"],"issn-type":[{"value":"2365-421X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The mice and rats in this study were maintained and handled in accordance with the National Research Council\u2019s Guide for the Care and Use of Laboratory Animals, as well as the specific institutional guidelines. The experimental protocols involving animals were thoroughly reviewed and approved by the Animal Ethics Committees of Fudan University and the National Institutes for Quantum Science and Technology. These approvals ensure that all procedures complied with ethical standards for the humane treatment of animals, reflecting the researchers\u2019 commitment to ethical scientific practices and the welfare of the animals involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}